Bayer Signs a Non-Exclusive Licensing Agreement with ProteoNic Biotechnology for its 2G UNic Technology

Shots:

• Bayer to get non-exclusive WW license rights to develop and commercialize its own products by using ProteoNic’s 2G UNic Technology 
• The focus of the collaboration is to produce and enhance Bayer recombinant proteins portfolio utilizing ProteoNic’s 2G UNic Technology
• ProteoNic’s 2G UNic Technology is a protein expression technology designed to improve cell line production levels exerting effects on recombinant protein production

 Click here to read full press release/ article | Ref: ProteoNic Biotechnology | Image: AgNewsWire